Skip to content

The Pediatric Antiretroviral Pipeline

July 15, 2016 By Polly Clayden INTRODUCTION The development of new antiretroviral drugs and appropriate formulations for children continues to be far too slow. There are now 2.6 million children in need of antiretroviral treatment (ART) globally. Of those treated,…

Read more

The Antiretroviral Pipeline

July 15, 2016 By Tim Horn and Simon Collins INTRODUCTION The year 2016 marks 20 years since combination-based antiretroviral therapy (ART) first demonstrated durable, effective and sustained HIV control. An unprecedented period of drug discovery followed, and advances in viral…

Read more

Fit For Purpose: Antiretroviral Treatment Optimization

July 15, 2016 By Polly Clayden INTRODUCTION Since the 2015 Pipeline Report global antiretroviral treatment (ART) guidelines have moved to recommending “treat all” HIV positive people. With this recommendation comes the massive task of starting and keeping everyone with HIV…

Read more

Executive Summary

July 15, 2016 By Mark Harrington Executive Summary - HIV THE ANTIRETROVIRAL TREATMENT PIPELINE In their chapter on Antiretroviral Treatment in this year’s Pipeline Report [9], Tim Horn and Simon Collins provide a sweeping overview of developments in the past…

Read more

Dedications

THIS REPORT IS DEDICATED TO Margie Garber-Steinberg April 7, 1949 – April 14, 2016   This edition of the Pipeline Report is dedicated to Margie Garber-Steinberg, mother of long-time board member Jason Osher. Margie was a steadfast TAG supporter for…

Read more

The Tuberculosis Vaccine Pipeline

February 2013 Update On Feburary 4, 2013, results from the phase IIb trial of the MVA85A vaccine in infants in South Africa (given as a booster following BCG immunization) were published in the Lancet. The vaccine proved safe but, disappointingly,…

Read more

The Tuberculosis Treatment Pipeline

Updates to this chapter can be found in the postscript at the end of this page. Original Report July 2012 By Erica Lessem Introduction Tuberculosis (TB) persists as a global health problem, suffering from both insufficient funding and political will.…

Read more
Back To Top